Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C

BACKGROUND: Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS One
Main Authors: Davitkov, Perica, Chandar, Apoorva Krishna, Hirsch, Amy, Compan, Anita, Silveira, Marina G., Anthony, Donald D., Smith, Suzanne, Gideon, Clare, Bonomo, Robert A., Falck-Ytter, Yngve
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2016
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065164/
https://ncbi.nlm.nih.gov/pubmed/27741230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0163945
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים